Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNJ | NVO | ABBV | ||
| Company | Johnson & Johnson | Novo Nordisk A/S ADR | Abbvie Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 155.90 | 103.91 | 174.34 | ||
| High | 157.12 | 106.24 | 178.86 | ||
| Low | 154.11 | 103.86 | 173.50 | ||
| Last | 154.52 | 105.20 | 176.66 | ||
| Change | -0.98 | +2.57 | +4.93 | ||
| % Change | -0.63% | +2.50% | +2.87% | ||
| Volume | 4,269,907 | 4,476,886 | 6,415,361 | ||
| 20-Day Average Volume | 7,294,293 | 6,729,168 | 7,679,531 | ||
| Previous Close | 155.50 | 102.63 | 171.73 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 156.37 | 107.37 | 184.58 | ||
| 20-Day Raw Stochastic | 38.91% | 41.91% | 31.21% | ||
| 20-Day Relative Strength | 43.07% | 40.24% | 42.94% | ||
| Weighted Alpha | +0.60 | -10.73 | +17.54 | ||
| Today's Opinion | 24% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 11/15/24 | +3.63% since 11/15/24 | +7.52% since 11/15/24 | ||
| Low | 151.81 on 11/20/24 | 99.42 on 11/18/24 | 163.81 on 11/19/24 | ||
| High | 157.12 on 11/22/24 | 106.24 on 11/22/24 | 178.86 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | -5.05% since 10/22/24 | -9.48% since 10/22/24 | -6.02% since 10/22/24 | ||
| Low | 150.76 on 11/14/24 | 99.42 on 11/18/24 | 163.81 on 11/19/24 | ||
| High | 166.00 on 10/23/24 | 116.43 on 10/23/24 | 207.32 on 10/31/24 | ||
| 3-Month | |||||
| %Chg | -4.40% since 08/22/24 | -22.98% since 08/22/24 | -9.67% since 08/22/24 | ||
| Low | 150.76 on 11/14/24 | 99.42 on 11/18/24 | 163.81 on 11/19/24 | ||
| High | 168.85 on 09/04/24 | 139.74 on 08/30/24 | 207.32 on 10/31/24 | ||
| 6-Month | |||||
| %Chg | +1.11% since 05/22/24 | -21.34% since 05/22/24 | +11.14% since 05/22/24 | ||
| Low | 143.71 on 05/29/24 | 99.42 on 11/18/24 | 153.58 on 05/30/24 | ||
| High | 168.85 on 09/04/24 | 148.15 on 06/25/24 | 207.32 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 374,385,408 | 460,555,456 | 303,470,944 | ||
| Shares Outstanding, K | 2,407,623 | 4,487,532 | 1,767,140 | ||
| Annual Sales | 85,159,000,000 | 33,724,300,000 | 54,318,000,000 | ||
| Annual Net Income | 35,153,000,000 | 12,150,770,000 | 4,863,000,000 | ||
| Last Quarter Sales | 22,471,000,000 | 10,511,240,000 | 14,460,000,000 | ||
| Last Quarter Net Income | 2,694,000,000 | 4,024,170,000 | 1,561,000,000 | ||
| 60-Month Beta | 0.53 | 0.42 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.42 on 10/15/24 | 0.90 on 11/06/24 | 3.00 on 10/30/24 | ||
| Latest Earnings Date | 10/15/24 | 11/06/24 | 10/30/24 | ||
| Most Recent Dividend | 1.240 on 08/27/24 | 0.362 on 08/16/24 | 1.550 on 10/15/24 | ||
| Next Ex-Dividends Date | 11/26/24 | 08/16/24 | 01/15/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 14.95 | 34.07 | 15.61 | ||